BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 574957)

  • 1. Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):309-17. PubMed ID: 574957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course of apomorphine in the brain of the immature rat after apomorphine injection.
    Symes AL; Lal S; Soukes TL
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):260-4. PubMed ID: 1033736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural manifestations elicited by apomorphine, influence of the route of administration.
    Barros HM; Braz S; Carlini EA
    Pharmacology; 1989; 38(5):335-40. PubMed ID: 2762376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of some antidepressant drugs on apomorphine concentration in the central nervous system of rats and apomorphine-induced stereotypy.
    Rurak A; Melzacka M
    Pol J Pharmacol Pharm; 1985; 37(4):509-15. PubMed ID: 3866221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
    Lu W; Jiang W; Chen J; Yin M; Wang Z; Jiang X
    Int J Pharm; 2008 Feb; 349(1-2):196-205. PubMed ID: 17904315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral pharmacokinetics of apomorphine in humans.
    Gancher ST; Woodward WR; Boucher B; Nutt JG
    Ann Neurol; 1989 Aug; 26(2):232-8. PubMed ID: 2774511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of amizil and galantamin on the behavioral effects of apomorphine in rats].
    Bandman AL; Andriianov AI
    Biull Eksp Biol Med; 1981 Nov; 92(11):566-9. PubMed ID: 7198494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on behavioral responses and tissue levels of apomorphine in the rat.
    Campbell A; Baldessarini RJ; Stoll A; Teicher MH; Maynard P
    Neuropharmacology; 1984 Jul; 23(7A):725-30. PubMed ID: 6540844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies.
    Liou HH; Chen RC; Tsai YF; Chen WP; Chang YC; Tsai MC
    Toxicol Appl Pharmacol; 1996 Mar; 137(1):34-41. PubMed ID: 8607139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral tolerance to chronic apomorphine administration in rats.
    Wooten GF; Cheng CH
    Trans Am Neurol Assoc; 1979; 104():219-21. PubMed ID: 576005
    [No Abstract]   [Full Text] [Related]  

  • 17. Haloperidol-induced changes in the regional cerebral pharmacokinetics of apomorphine.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):387-91. PubMed ID: 523341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.
    Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diphasic action of apomorphine on motility in the rat. II. Time aspects of the effect of a single dose].
    Vaccheri A; Gandolfi O; Dall'Olio R; Montanaro N
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):381-6. PubMed ID: 7236418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical and behavioral correlates of chronic apomorphine administration in the rat.
    Kenny M; Leonard BE
    Adv Biochem Psychopharmacol; 1978; 19():347-9. PubMed ID: 567934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.